Supreme Court Grants Temporary Reprieve for Abortion Pill But Final Ruling Still Uncertain

A federal judge suspended FDA approval of the abortion pill mifepristone, threatening access nationwide.
The Biden administration and mifepristone manufacturer appealed to the Supreme Court to restore access.
The Supreme Court temporarily restored full access to mifepristone pending further review.
The ruling increases restrictions on mifepristone, limiting use to seven weeks of pregnancy and banning telehealth and mail delivery.
The fate of mifepristone remains uncertain as the Supreme Court considers conflicting rulings from appeals courts.